Whalen DA, Hamilton DG, Ganote CE, et al: Effect of a transient period of ischemia on myocardial cells: I. Effects on cell volume regulation.Am J Pathol 74: 381–397, 1974
PubMed
CAS
Google Scholar
Jennings RB, Ganote CE, Whalen DA: Recent advances in studies on cardiac structure and metabolism. Baltimore, University Park Press, pp 405–413, 1975
Google Scholar
Bouchardy B, Majno G: Histopathology of early myocardial infarcts.Am J Pathol 74: 301–330, 1974
PubMed
CAS
Google Scholar
Ashraf M, White F, Bloor CM: Ultrastructural influences of reperfusing dog myocardium with calcium-free blood after coronary artery occlusion.Am J Pathol 90: 423–434, 1978
PubMed
CAS
Google Scholar
Reimer KA, Lowe JE, Jennings RB: Effect of the calcium antagonist verapamil on necrosis following temporal coronary artery occlusion in dogs.Circulation 55: 581–587, 1977
PubMed
CAS
Google Scholar
Kloner RA, Deboer JE, Carlson, et al: The effect of verapamil on myocardial ultrastructure during and following release of coronary artery occlusion.Exp Mol Pathol 36: 277–286, 1982
PubMed
Article
CAS
Google Scholar
Wende W, Bleifeld W, Meyer J, et al: Reduction of the size of acute experimental myocardial infarction by verapamil.Basic Res Cardiol 70: 198–208, 1975
PubMed
Article
CAS
Google Scholar
Smith HJ, Singh BN, Norris RM, et al: The effect of verapamil on experimental myocardial ischemia with particular reference to regional myocardial blood flow and metabolism.Aust NZ J Med 7: 114–121, 1977
CAS
Google Scholar
Lefer AM, Polansky EW, Bianchi CP: Influence of verapamil on cellular integrity and electrolyte concentration of ischemic myocardial tissue in the cat.Basic Res Cardiol 74: 555–567, 1979
PubMed
Article
CAS
Google Scholar
Magee PG, Flaherty JT, Bixler TJ, et al: Comparison of myocardial protection with nifedipine and potassium.Circulation 60 (suppl I): 151–157, 1979
PubMed
CAS
Google Scholar
Clark RE, Christlieb IY, Henry PD, et al: Nifedifine: A myocardial protective agent.Am J Cardiol 44: 825–831, 1979
PubMed
Article
CAS
Google Scholar
Watte JA, Koch CD, LaNoue KF: Effect of Ca antagonism on energy metabolism: Ca and heart function after ischemia.Am J Physiol 238: H909-H916, 1980
Google Scholar
Nayer WG, Ferrari R, Williams A: Protective effect of pretreatment on mitochondrial function in ischemic and reperfused myocardium.Am J Cardiol 46: 242–248, 1980
Article
Google Scholar
Frame LH, Lopez JA, Khaw BA, et al: Early membrane damage during coronary reperfusion in dogs. Detection by radiolabeled anticardiac myosin F(ab)’2.J Clin Invest 71: 535–544, 1983
Article
Google Scholar
Karlsberg RP, Henry PD, Ahmed SA, et al: Lack of protection of ischemic myocardium by verapamil in conscious dog.Eur J Pharmacol 42: 339–346, 1977
PubMed
Article
CAS
Google Scholar
Lo H-M, Kloner RA, Braunwald E: Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: Critical importance of the timing of treatment.Am J Cardiol 56: 672–677, 1985
PubMed
Article
CAS
Google Scholar
Harbert J, da Rocha AFG. Textbook of nuclear medicine. 2nd ed. Philadelphia: Lea & Febiger; 59–60, 1984
Google Scholar
Braunwald E: Symposium on modern thrombolytic therapy.J Am Coll Cardiol 10 (suppl B): 1B-104B, 1987
Article
Google Scholar
Puri PS: Contractile and biochemical effects of coronary reperfusion after extended periods of coronary occlusion.Am J Cardiol 36: 244–251, 1975
PubMed
Article
CAS
Google Scholar
Kloner RA, Ganote CE, Whalen DA Jr, et al: Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of a reflow.Am J Pathol 74: 399–422, 1974
PubMed
CAS
Google Scholar
Jennings RB, Sommers HM, Kaltenbach JP, et al: Electolyte alterations in acute myocardial ischemic injury.Circ Res 14: 260–269, 1964
PubMed
CAS
Google Scholar
Lang T-W, Corday E, Gold H, et al: Consequences of reperfusion after coronary occlusion. Effect of hemodynamic and regional myocardial metabolic function.Am J Cardiol 33: 69–81, 1974
PubMed
Article
CAS
Google Scholar
Keete DL, Kates RE: Myocardial deposition and cardiac pharmacodynamics of verapamil in the dog.J Pharmocol Exp Ther 220: 91–96, 1982
Google Scholar
Festisova TV, Zabolotnyuk IP: Changes in heart muscle and liver proteins in experimental myocardial infarction.Fed Proc 24: T960-T962, 1965
Google Scholar
Khaw BA, Beller G A, Haber E, et al: Localization of cardiac myosin specific antibody in myocardial infarction.J Clin Invest 58: 439–446, 1976
PubMed
Article
CAS
Google Scholar
Khaw BA, Scott J, Fellon JT, et al: Quantitation by cell sorting initiated with antimyosin fluorescent sphere.Science 217: 1050–1053, 1982
PubMed
Article
CAS
Google Scholar
Khaw BA, Beller GA, Habe E: Experimental myocardial infarction imaging following intravenous administration of 131-1 labeled antibody (Fab)’2 fragment specific for cardiac myosin.Circulation 57: 743–750, 1978
PubMed
CAS
Google Scholar
Khaw BA, Gold HK, Leinbach RC, et al: Early imaging of experimental myocardial infarction by intracoronary administration of131I-labeled anticardiac myosin (Fab)’2 fragment.Circulation 58: 1137–1142, 1978
PubMed
CAS
Google Scholar
Senekowitsch R, Kriegel H, Baum RP, et al: Biokinetic studies and scintigraphic imaging of human carcinoma xenografts with radiolabeled monoclonal antibodies. In Srivastava SC(ed):Radiolabeled monoclonal antibodies for imaging and therapy. New York, Plenum, pp 323–341, 1988
Google Scholar